Companies: 48,687 Total Market Cap: 126956050782004.97

Boston Scientific

NYSE: BSX
Healthcare Medical Devices
Rank #97
Market Cap 155.20 B
Volume 7.36 M
Price 104.93
Change (%) 1.69%
Country or region United States United States

Boston Scientific's latest marketcap:

155.20 B

As of May 2, 2025, Boston Scientific's market capitalization has reached $155.20 B. According to our data, Boston Scientific is the 97th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 155.20 B
Revenue (ttm) 17.55 B
Net Income (ttm) 2.03 B
Shares Out 1.48 B
EPS (ttm) 1.37
Forward PE 35.61
Ex-Dividend Date n/a
Earnings Date April 23, 2025
Market Cap Chart
Data Updated: May 2, 2025

Boston Scientific's yearly market capitalization.

Boston Scientific has seen its market value grow from $10.53 B to $150.80 B since 1998, representing a total increase of 1,331.48% and an annual compound growth rate (CAGR) of 10.64%.
Date Market Cap Change (%)
April 28, 2025 $150.80 B 14.55%
December 31, 2024 $131.64 B 55.44%
December 29, 2023 $84.69 B 27.79%
December 30, 2022 $66.27 B 9.48%
December 31, 2021 $60.53 B 17.59%
December 31, 2020 $51.48 B -18.33%
December 31, 2019 $63.03 B 28.88%
December 31, 2018 $48.90 B 43.66%
December 29, 2017 $34.04 B 15.58%
December 30, 2016 $29.45 B 18.74%
December 31, 2015 $24.81 B 41.13%
December 31, 2014 $17.58 B 9.51%
December 31, 2013 $16.05 B 104%
December 31, 2012 $7.87 B -0.56%
December 30, 2011 $7.91 B -31.25%
December 31, 2010 $11.51 B -15.35%
December 31, 2009 $13.59 B 16.97%
December 31, 2008 $11.62 B -32.97%
December 31, 2007 $17.34 B -31.53%
December 29, 2006 $25.32 B 26.18%
December 30, 2005 $20.07 B -33.15%
December 31, 2004 $30.02 B -0.3%
December 31, 2003 $30.11 B 73.64%
December 31, 2002 $17.34 B 78.25%
December 31, 2001 $9.73 B 75.34%
December 29, 2000 $5.55 B -38.85%
December 31, 1999 $9.07 B -13.86%
December 31, 1998 $10.53 B

Company Profile

About Boston Scientific Corporation

Boston Scientific Corporation is a global leader in developing, manufacturing, and marketing medical devices for interventional medical specialties. Headquartered in Marlborough, Massachusetts, the company was founded in 1979 and operates through two primary segments: MedSurg and Cardiovascular.

Key Product Offerings

  • MedSurg Segment:
    • Gastrointestinal solutions, including resolution clips, biliary stent systems, and single-use duodenoscopes.
    • Urological devices such as ureteral stents, catheters, and laser systems.
    • Neurological products for chronic pain management, including spinal cord stimulators and deep brain stimulation systems.
  • Cardiovascular Segment:
    • Technologies for coronary artery disease and aortic valve conditions.
    • WATCHMAN FLX, a left atrial appendage closure (LAAC) device.
    • Implantable cardiac devices like defibrillators, pacemakers, and remote monitoring systems.

Additional Specialties

The company also provides solutions for:

  • Peripheral arterial and venous diseases.
  • Diagnosis and treatment of cardiac rhythm disorders.
  • Oncology products for cancer diagnosis and treatment.

Boston Scientific continues to innovate in medical technology, improving patient outcomes across a wide range of conditions.

Frequently Asked Questions

As of May 2, 2025, Boston Scientific (including the parent company, if applicable) has an estimated market capitalization of $155.20 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Boston Scientific global market capitalization ranking is approximately 97 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1979
IPO Date May 18, 1992
Employees n/a
CEO Michael Mahoney
Sector Healthcare
Industry Medical Devices
Address 300 Boston Scientific Way
Marlborough, Massachusetts 01752-1234
United States